Alice Callard

603 citations
5 papers · 414 indexed · h-index 4
Topics
BRCA gene mutations in cancer (3 papers)Pharmaceutical studies and practices (2 papers)Glycosylation and Glycoproteins Research (1 paper)

In The Last Decade

Alice Callard

5 papers receiving 405 citations

Peers

Alice Callard
Comparison fields: 5 of 59
  • Molecular Biology 332
  • Oncology 122
  • Cell Biology 71
  • Immunology 56
  • Epidemiology 54
Replace Ricarda Schwab with:
Ricarda Schwab Germany
Prashant Sharma United States
Maike Schmitz Germany
Oscar W. Huang United States
Chris Riffkin Australia
Xavier H. Mascle Canada
Takahiko Seki Japan
Stephen Tirrell United States
Harish Potu United States
Harasim Thomas Germany
Alice Callard relative to Ricarda Schwab Germany Ricarda Schwab's profile →
Citations per field
00.5×1.5×
Ricarda Schwab · 1×
Citations per year

Countries citing papers authored by Alice Callard

Since Specialization
Citations

This map shows the geographic impact of Alice Callard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Callard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Callard more than expected).

Fields of papers citing papers by Alice Callard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Callard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Callard. The network helps show where Alice Callard may publish in the future.

Co-authorship network of co-authors of Alice Callard

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Callard. A scholar is included among the top collaborators of Alice Callard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Callard. Alice Callard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1
Delivering a pharmacogenetic service in the NHS: is there a role for genetic counsellors?
1
2 17
3 11
4 43
5 342

About Alice Callard

Alice Callard is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Genetics, having authored 5 papers that have together received 414 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (3 papers), Pharmaceutical studies and practices (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Molecular Biology (332 citations), Hematology (53 citations) and Oncology (122 citations). Alice Callard has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Alfred L. Goldberg, Alexei F. Kisselev, William G. Newman, Katherine Payne, Katy J. McCann, Raymond A. Dwek, Heather Skirton, Christian H. Ottensmeier, Brian J. Sutton and David J. Harvey. Their work appears in journals such as Journal of Biological Chemistry, Molecular Immunology and Journal of Genetic Counseling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026